FDA.reportPublic FDA data

betamethasone dipropionate 0.64 MG/ML / calcipotriene 0.05 MG/ML Topical Cream

RxCUI
2471873
RxNorm name
betamethasone dipropionate 0.64 MG/ML / calcipotriene 0.05 MG/ML Topical Cream
Display name
betamethasone dipropionate 0.64 MG/ML / calcipotriene 0.05 MG/ML Topical Cream
Full name
betamethasone dipropionate 0.64 MG/ML / calcipotriene 0.05 MG/ML Topical Cream
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:54

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
WynzoraCALCIPOTRIENE AND BETAMETHASONE DIPROPIONATEMC2 Therapeutics Ltd36c5c818-0d40-445e-a3c0-0f46723a25e22023-11-29Warnings, Adverse reactionsExact identifier
rxcui: 2471873

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
36c5c818-0d40-445e-a3c0-0f46723a25e2betamethasone dipropionate 0.064 % / calcipotriene 0.005 % Topical Cream [PSN] · betamethasone dipropionate 0.64 MG/ML / calcipotriene 0.05 MG/ML Topical Cream [SCD] · betamethasone dipropionate 0.064 % / calcipotriene 0.005 % Topical Cream [SY]36These highlights do not include all the information needed to use WYNZORA Cream safely and effectively. See full prescribing information for WYNZORA Cream. WYNZORA ® (calcipotriene and betamethasone dipropionate) cream, for topical use Initial U.S. Approval: 202020231129